Mind Medicine Inc (NASDAQ: MNMD) on Thursday, soared 5.68% from the previous trading day, before settling in for the closing price of $5.46. Within the past 52 weeks, MNMD’s price has moved between $4.70 and $10.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 36.90%. With a float of $74.09 million, this company’s outstanding shares have now reached $75.37 million.
Let’s determine the extent of company efficiency that accounts for 74 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 1.10%, while institutional ownership is 49.60%. The most recent insider transaction that took place on Mar 25 ’25, was worth 142,942. In this transaction Chief Executive Officer of this company sold 21,208 shares at a rate of $6.74, taking the stock ownership to the 856,556 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Chief Medical Officer sold 6,836 for $6.74, making the entire transaction worth $46,075. This insider now owns 446,177 shares in total.
Mind Medicine Inc (MNMD) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.90% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 7.00 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Looking closely at Mind Medicine Inc (NASDAQ: MNMD), its last 5-days average volume was 0.79 million, which is a drop from its year-to-date volume of 1.89 million. As of the previous 9 days, the stock’s Stochastic %D was 79.13%. Additionally, its Average True Range was 0.54.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 18.65%, which indicates a significant decrease from 78.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.45% in the past 14 days, which was higher than the 87.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.69, while its 200-day Moving Average is $6.90. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $5.92. Second resistance stands at $6.08. The third major resistance level sits at $6.31. If the price goes on to break the first support level at $5.53, it is likely to go to the next support level at $5.30. Now, if the price goes above the second support level, the third support stands at $5.14.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
Market capitalization of the company is 434.88 million based on 75,368K outstanding shares. Right now, sales total 0 K and income totals -108,680 K. The company made 0 K in profit during its latest quarter, and -34,740 K in sales during its previous quarter.
